Omega Says Bank's Rug-Pull Led Cash-Strapped Co. To Ch. 11
By Emlyn Cameron · February 12, 2025, 9:04 PM EST
Biotechnology company Omega Therapeutics, which hit Chapter 11 this week with over $140 million of debt and a restructuring agreement, has said it became insolvent because a bank that gave it...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login